About AKAGERA MEDICINES INC
Akagera Medicines is a private Delaware-registered biotech company founded in 2018 in Kigali, Rwanda, focused on developing novel liposomal formulations of antibacterial drugs to treat tuberculosis and other infectious diseases. It is majority-owned by the people of Rwanda and has laboratories in Boston and San Francisco.
Development of novel and patented liposomal formulations of antibacterial drugsMechanism of action involving increased delivery and uptake of liposomal nanoparticles into macrophagesTherapeutic development for MRSA and vaccine candidates for Tuberculosis, Lassa Fever, HIV, RSV, and InfluenzaPartnerships with THE GATES FOUNDATION, NIH-VRC, CEPI, and a public pharmaceutical company
Teaming History
Prime contractors AKAGERA MEDICINES INC has worked under:
- Seattle Children'S Hospital — 1 subcontract(s)
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to AKAGERA MEDICINES INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.